1990-2013年泌尿系统癌症的全球负担
该研究基于全球生命登记和癌症登记数据,采用集成建模方法估计1990至2013年肾癌、膀胱癌和前列腺癌的发病率、死亡率及风险因素归因死亡。
要点
- 1990至2013年死亡率增加1.6倍,男性年龄标化死亡率在发达国家最高。
- 吸烟归因肾癌死亡下降而肥胖相关死亡上升,发展中国家女性最明显。
核心结论
- 全球泌尿系统癌症负担在人口增长和老龄化背景下增加。
- 高收入国家发病率和死亡率最高,但发展中国家肥胖归因肾癌死亡增加。
- 扩大全球肿瘤专业队伍和减少可预防因素可能减轻发展中国家的癌症差异。
研究设计与样本
- 癌症死亡率数据来自全球生命登记,发病率数据来自癌症登记。
- 使用单独估计的死亡率/发病率比对发病率数据进行转换,并作为集成建模方法的输入数据。
- 病因别死亡率估计通过死亡率/发病率比转换为发病率估计。
主要发现
- 1990至2013年死亡率增加1.6倍。
- 在三种癌症中,发达国家男性的年龄标化死亡率最高。
- 吸烟归因肾癌死亡下降而肥胖相关死亡上升,在发展中国家女性中最明显;吸烟相关膀胱癌死亡在发达国家女性中增加而在男性中下降。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Kidney, prostate, and bladder cancers increase with age and are influenced partly by modifiable risk factors. Urological cancer rates may increase substantially amid a growing, aging population. OBJECTIVE: To describe kidney, bladder, and prostate cancer incidence, mortality, and risk factor-attributable bladder and kidney cancer deaths between 1990 and 2013, by age, sex, and development status. EVIDENCE ACQUISITION: Cancer mortality data were derived from global vital registries. Incidence data from cancer registries were transformed to mortality estimates using separately estimated mortality incidence ratios. These sources served as input data for an ensemble modeling approach to estimate bladder, prostate, and kidney cancer mortality. Cause-specific mortality estimates were transformed into incidence estimates using mortality incidence ratios. EVIDENCE SYNTHESIS: In 2013, 2.1 million kidney, bladder, and prostate cancers cases occurred worldwide, increasing 2.5-fold since 1990. Mortality increased 1.6-fold between 1990 and 2013. Eight-two percent of new cases in 2013 occurred in individuals aged 60 yr and older. Men from developed countries had the highest age-standardized death rates among all three cancers. Smoking-attributable kidney cancer deaths decreased while obesity-related deaths rose, most prominently in women from developing countries. Smoking-related bladder cancer deaths increased among women from developed countries and decreased among men. CONCLUSIONS: Urologic cancer burden has increased globally amid population growth and aging. High income countries face the highest incidence and death rates; however, obesity-attributed kidney cancer deaths are increasing in developing countries. Efforts to expand the global oncologic workforce and reduce preventable factors may lessen cancer disparities in developing countries. PATIENT SUMMARY: We describe the impact of population growth, aging, and lifestyle factors such as smoking and obesity, on kidney, bladder, and prostate cancer rates worldwide. More new cancer cases and deaths occur in developed countries compared with developing countries. In addition to preventive efforts, healthcare systems must emphasize training of a urologic oncology workforce.
引用
- Dy GW, Gore JL, Forouzanfar MH, et al. Global Burden of Urologic Cancers, 1990-2013. Eur Urol. 2016. PMID: 28029399. doi:10.1016/j.eururo.2016.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。